










CARLO CAIATI, MD,* PIERLUIGI ARAGONA, MD,
RAFFAELE VERDE, MD, REINHARD SCHLIEF, MD,t PAOLO RIZZON, MD
Bari and Cassano Murge, 1,aly and Berlin, Germany
Objectives .
We tested the hypothesis that SHU 798A, a new
lung-crossing contrast agent capable of increasing the Doppler
signal to noise ratio in the right heart as well as left heart cavities
after intravenous injection, could increase Doppler signal
intensity
in coronary arteries, thus improving the feasibility and quality of
transesophageal Doppler echocardiographic evaluation of coro-
nary b low velocity .
Background. Coronary bd flow velocity can be evaluated by
t phageal Doppler echocardiography . However, an ade.
quate Doppler tracing is obtainable in a relatively low percent of
patients.
Methods. Transesophageal Doppler echocardiography of corn •
nary arteries was performed in 35 patients before and after SHU
A injection at four different dosages (200 mg/ml in 5 ml,
200 mg(nd in 10 ml, 300 mg/ml in 5 ml and 300 mgimi in 10 ml) .
Color Doppler mapping of coronary low and pulsed wave Dopp .
ler measurement of coronary blood flow velocity were attempted
in all patients .
Results . Color Doppler flow mapping of 105 evaluated coro-
nary segments (left main, left anterior descending and circumflex
in 35 patients) was not detectable or was weak in % of patients
before and 33% of patients after echo contrast injection (p <
Coronary blood flow velocity and coronary flow reserve can
be assessed using transesophageal Doppler echocardiogra-
phy (1-4) . In fact, it has recently been demonstrated that
pulsed wave recording of coronary blood flow velocity can
be obtained in baseline conditions, as well as during drug-
induced vasodilation (2,5-10) . However, even if this new
investigative tool is reliable and promising, its research and
clinical applications are hampered by the fact that its poten-
tial is limited because in a certain percent of patients, the
coronary Doppler signal intensity and signal to noise ratio
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0 . 1) ; it was optimal (that is, well delineated with complete flow
mapping of the explored vessel) in only 11% of patients before d
67% after echo contrast injection (p < D . 1). In addition,
pulsed wave Doppler signal quality improved after echo contrast
injection : Pulsed wave Doppler recording of coronary blood flow
velocity was not obtainable or was weak in 78% of cases before
and 34% after echo contrast injection (p < 0.001); ptds wave
Doppler recording of coronary blood flow velocity was optimal
(that is, there was a complete and well defined outline of diastolic
coronary bd flow velocity in 23% of cases before and 66% after
echo contrast injection lp < 0 .00011 . Both length and width of
color Doppler mapping in the left anterior descending coronary
artery increased after 5111508A injection (from 5.75 t 5.32 and
1.51 ± 1.17 to 17 .44 ± 8.76 and 4.21 ± 1.78 , respectively,
mean ± SD, P < 0 .0041).
Conclusions. The feasibility and quality of recording coronary
bl flow velocity by transesophageal Doppler echocardiography
are considerably improved by intravenous injection of S 508A .
The improved feasibility of this new semi-invasive method for
evaluating coronary b1 flow velocity and Row reserve can
considerably increase its research and clinical utilization .
(i Am Colt' Cardiol 1994,23 :184-90)
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are not high enough to obtain adequate Doppler tracings or
color flow maps.
SHU 508A is a recently developed lung-crossing echo-
enhancing agent (11-13) that is a derivative of SHU 454,
whose ability to increase Doppler signal intensity as well as
the signal to noise ratio has been demonstrated in in vitro
and in vivo studies (14-17). Recent studies (11,13,16,17)
have shown that intravenous peripheral injection of SITU
508A greatly enhances blood echogenicity not only in right
heart but also in left heart cavities after pulmonary transit.
We hypothesized that intravenous injection of SHU 508A
could also enhance Doppler signal intensity and thus the
signal to noise ratio in coronary arteries and that this
improvement would consequently lead to an increase in the
feasibility and quality of transesophageal Doppler recordings
of coronary blood flow velocity . We undertook this study to
verify this hypothesis .
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IMPROVED DOPPLER SIGNAL INTENSITY AFTER SHU 508A
Methods
Thirty-five patients (24 men and H women, mean age
58 ± 11 years) undergoing transesophageal echocaridio-
graphic examination for diagnostic purposes entered the
study, Twenty-five patients had coronary artery disease
(nine had a previous myocardial infarction), seven had
valvular heart disease, two had an ischemic stroke and one
had ventricular arrhythmias. All patients were informed of
the purpose and nature of the research study and all pro-
vided consent. Exclusion criteria for the study were galac-
tosemia, age < 18 years, acute life-threatening diseases,
recent (<3 months) myocardial infarction and pregnancy .
Transesophageni echocardlography . Transesophageal
echocardiography was performed after sedation by intrave-
nous injection of a small amount of diazepam, with the
patient lying in the left lateral decubitus position . Doppler
echocardiography (color and pulsed wave) was performed
either with Acuson XP 125, HP Sows 1000 or HP Sonos 500
equipment with a 5-MHz iransesophageal transducer . Im-
ages were permanently recorded on a 0 .75 in. (1 .9 cm)
videotape for later review and analysis . After completing the
diagnostic part of the examination, the transducer was
placed at the level of the aortic root and left coronary artery
imaging was attempted .
Echocardiographic imaging of the proximal left coronary
artery (left main coronary artery, bifurcation, proximal
circumflex, left anterior descending) was obtained with the
transducer located at the level of the aortic root . Since net all
proximal left coronary segments can be visualized on the
same tomographic plane, once the proximal part of the left
main coronary artery was visualized, small adjustments of
the orientation of the ultrasonic beam were made to image
different coronary segments (15,19), When optimal echocar-
diographic imaging of the left coronary artery was achieved,
color Doppler recording was performed . As for echocardio-
graphic imaging, further minor adjustments of the tomo-
graphic plane orientation were performed to optimize the
color Doppler recordings .
Coronary blood flow velocity tracing in the left anterior
descending coronary artery was obtained by means of pulsed
wave Doppler exploration of the most proximal part of the
vessel. Pulsed wave Doppler sample volume positioning was
performed with the help of color Doppler imaging by con-
sidering the diastolic position of the explored vessel (2) .
Owing to the absence of ventricular contraction in diastole,
the position of the left anterior descending coronary artery is
more stable, thus facilitating sample volume positioning .
In this study we used SHU 508A, a new lung-crossing
contrast agent. SHU 508A is a suspension of monosaccha-
ride (galactose) microparticles in sterile water (11-13) . These
microparticles have a median diameter of 2 gzm . Contrast
medium was prepared 2 to 10 min before being intravenously
injected by adding the amount of sterile water required to
obtain the desired contrast concentration . In this study, we
used concentrations of 200 and 300 mg/mI . Once the sterile
185
water was added to SRI 508A raicroparticle granules, the
vial was shakers vigorously for --5 s . The prepared echo
contrast medium was manually injected (at approximately
2 mils) into a vein of the right arrn . Contrast injection was
immediately followed by a 5-ml bolus of physiologic saline
solution to flush the canpule and improve the bolus flow .
Study protocol . In -.11 patients, four injections were ad-
ministered : 5 and 10 ml of the 2W-mg/ml concentration and
5 and 10 ml of the 300-mg/mll concentration . Both color
Doppler flow mapping of the proximal left coronary artery
and color Doppler-guided pulsed wave imaging of the left
anterior descending artery were attempted before, during
and after each echo contrast injection . At least 5 min elapsed
between echo contrast injections . The electrocardiogram
(ECG) and blood pressure were monitored throughout trans-
esophageal Doppler echocardiographic study . The ECG was
repeated 24 h later .
Evaluation of Doppler data . Color Doppler mapping of
each of the three proximal left coronary segments was
evaluated
by two experienced observers both in baseline
conditions and during echo contrast injection. Color Doppler
flow image quality was graded from I to 3 . Grade I = flow
mapping not achieved or of very poor quality, grade 2 = not
well defined, incomplete flow mapping of the coronary
segment and grade 3 = optimal, well delineated and com-
plete flow mapping (optimal recording) . Flow mapping was
considered to be incomplete if either the coronary segment
was well defined by B mode imaging but not completely
"filled" by color flow mapping or if the vessel was not well
defined and the color Doppler signal had a width of 251 mm .
The coronary segment was judged as well defined when, by
B mode imaging, good visualization of the lumen-intima
interface (that is, the presence of two bright linear echoes
bounding the vessel lumen) was obtained . The length and
width of the color Doppler flow signal in the left anterior
descending artery were assessed, respectively, by measuring
the distance between the coronary bifurcation and the end of
color mapping in the vessel and the distance between color
flow mapping borders immediately after the bifurcation .
Pulsed wave quality was also evaluated and graded from I to
3 by both observers . Grade l = pulsed wave recording of
coronary blood flow velocity not obtainable, grade 2 =
recording obtainable but of suboptimal Doppler quality
(tracing incomplete with a poorly defined outline of diastolic
coronary blood flow velocity) and grade 3 = Doppler signal
with complete and well defined outline of diastolic coronary
blood flow velocity (optimal recording) . At each step of the
protocol, the number of patients with optimal recording of
both systolic and diastolic profiles was also assessed . Eval-
uation of both color and pulsed wave Doppler baseline and
echo contrast studies was performed blindly and in a random
sequence without knowledge of the phase of the protocol
during which images were recorded. Judgment of Doppler
recording was made by both observers (C .C. and P .A.) after
a consensus was achieved .
The duration of the contrast-induced Doppler enhance-
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Table 1 . Color Doppler Quality in Three Coronary Arteries After Intravenous Injection
ment effect was assessed by measuring the time interval
occurring between the beginning of the enhanced Doppler
color signal in the coronary arteries (this usually occurred
I to 2 s after the appearance of echo contrast color Doppler
enhancement in the left atrium) and the return of color
Doppler signal intensity to precontrast values .
After contrast injection, color Doppler intensity greatly
increased both in the left atrium and the coronary arteries .
However, because the left atrium was opacified first and
coronary arteries some cardiac cycles later, this temporal
sequence was useful in delineating different areas and cor-
rectly identifying the coronary arteries .
Inter. and infraobserver variability. To assess inter- and
intraobserver variability in evaluating echo contrast injec-
tion effects . 20 color and pulsed wave Doppler studies (10
baseline and 10 echo contrast studies) were independently
evaluated by two observers . The same observer evaluated 10
baseline and 10 echo contrast studies twice, I month apart .
Statistics. Continuous values are expressed as mean
value :t SD. Doppler variables before and after contrast
injection were compared . Chi-square analysis was used to
determine if a difference existed among coronary segment
distribution within the three grades of Doppler signal judg-
ment in five different conditions : baseline and after four
different dosages of contrast medium (contingency table,
three rows times five columns) . Multiple comparisons within
the groups (contingency table, three rows times two col-
umns) were performed ; p < 0 .01 was considered significant .
A paired t test was used to assess whether differences
existed between length and width of color Doppler signals in
the left anterior descending artery before and after contrast
injection ; p < 0.05 was considered significant .
Results
In our patient groups, injection of SHU 508A consider-
ably increased color and pulsed wave Doppler signal inten-
sity (Tables I and 2 . Fig. I and 2) . Figures 3 to 5 show
representative color and pulsed wave Doppler images (base-
line and contrast studies) . Blood pressure and the ECG were
observed during contrast injection ; no adverse events or
changes in heart rate were found
. In Tables I and 2, the
A
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Data presented are number (%) of coronary artery segments with a specific score
. LAD = left anterior descending coronary artery : LCx = left circumflex
coronary artery
; LMCA = left main coronary artery
; Score I = absent color flow mapping ; Score 2 = incomplete color flow mapping, Score 3 = complete color
flow mapping
; Ist dose = 5 ml of 2Wmg1ml concentration, 2nd dose = 10 ml of 200-mg/ml concentration : 3rd dose = 5 ml of 300-mg/ml concentration, 4th dose
= 10 ml of 300-mg/ml concentration .
results of color and pulsed wave Doppler evaluation of blood
flow velocity in different coronary segments, at baseline
conditions as well as after each of the four contrast injections
are summarized .
Significant improvement in both color and pulsed wave
Doppler signal intensity was observed after each of the
four echo contrast injections (Table 1, Fig . 1) . In the 35
patients, 105 coronary segments were available for evalua-
tion (3 segments (main coronary artery, circumflex, left
anterior descending] for each of the 35 patients) . Color
Doppler flow mapping was not achieved (grade 1) in 53 (W)
of the 105 available coronary segments at baseline conditions
and only 18 (17%) after SHU 508A injection . Furthermore,
before contrast i njection. an optimal color Doppler map of
coronary flow (grade 3) was obtained in only 12 segments
(11%) (7 left main, 4 left anterior descending and I circum-
flex) . After SHU 508A injection of 10 ml at the 300-mg
concentration, optimal color Doppler flow mapping (grade 3)
was obtained in 70 segments (67% p ~ 0 .0MI vs . precon-
trast) (26 left main, 26 left anterior and 18 circumflex) .
A higher percent of optimal color Doppler recordings
(grade 3) was obtained with the 3Wmg/W concentration .
However, in 4 of 35 cases, a 10-ml injection at this Concen-
tration produced excessive enhancement in the initial phase
Table 2 . Pulsed Wave Doppler Quality in the Left Anterior







Data presented are number (%) of coronary artery segments with a
specific score . Score I = pulsed wave recording not obtainable ; Score 2 =
pulsed wave recording obtainable but of suboptimal quality (considering
diastolic curve) -, Score 3 = Doppler signal with complete and well defined
outline of diastolic curve ; Score 3 (systolic and diastolic) = Doppler signal
with complete and well defined outline of both diastolic and systolic curves ;
other definitions as in Table 1 .
LMCA Score
LAD Score LCx Score
2 3 I 2 I 2
Control 121341 16(46)
7(20) 13137) 18 (51) 4(11) 28 (80) 6(17) 1 (3)
1st dose 7(20) 7 (20) 21(60)
5(14) 110111 19(54) 19 (4) 5 (10 II t3I)
2nd dose 4(11) 7 (20
24(69) 4UD 7(20) 24(69) 15(43) 6 (17) 14 (40)
3rd dose 2(6)
6(17) 27(77) 4(11) 5(14) 26(74) 14(40) 5(14) 16(46)
4th dose 2(6) 7 (20) 26 (74)
4(11) 5(14) 26(74) 12(34) 5(14) 18 (51)
Control 1029) 17 (49) 8(23) 4(11%)
1st dose 5(14) 13(37) 17149) 10 QW0
2nd dose 5(14) 9(26) 21(60) 18(51%)
3rd dose 4(11) 8(23) 23(66) 21 (60%)
4th dose 4(11) 8(23) 23(66) 21(60%/)
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Figure I . Color Doppler quality in coronary arteries after four
dosages of SITU 508A . The five series of three bars in the graphs
represent the number of coronary segments with a specific score
(from grade t to grade 3) in five different conditions (at baseline and
after four different dosages of contrast medium) . The score signifi'
candy improves after injection of contrast medium * = p < 0 .0001
control versus each dosage of contrast medium . LAD = left anterior
descending coronary artery ; LCx = left circumiex coronary artery :
LMCA = left main
coronary
artery .
of bolus transit, thus making color evaluation of the coro-
nary artery impossible . This excessive increase was never
observed when the 300-mg/ml concentration was injected at
5-ml volume .
Contrast injection also increased pulsed Doppler signal
intensity (Table 2, Fig . 2). In fact, pulsed Doppler recording
of coronary blood flow velocity was not obtainable (grade 1)
in 10 patients (29%) before and in only 4 (11%) after echo
contrast injection . Furthermore, an optimal signal (grade 3 :
strong signal intensity, high signal to noise ratio, complete
diastolic curve outline definition) was observed in only 8
cases (23%) before and 23 cases (66%) after SHU 508A
injection (p < MOO . Only four patients (11%) had optimal
pulsed Doppler recording of both systolic and diastolic
coronary blood flow velocity before echo contrast injection .
In contrast, 21 patients (60%) had optimal systolic and
diastolic recording after SHU 508A injection .
After contrast injection, color Doppler-guided pulsed
Doppler sample volume positioning and coronary blood flow
velocity recording were obtained much more easily because
ILICEETO ET AL .
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Figure 2 . Pulsed wave Doppler quality in the left anterior descend-
ing coronary artery (LAD) after four dosages of S}1U 508A . The five
series of three bars in the graph represent the number of coronary
segments with a specific score (from grade I to grade 3) in five
conditions (at baseline and after four different doses of contrast
medium). The score significantly improves after the second, third
and fourth doses of contrast medium * = p < 0 .07 first dose versus
control : t = p < 0 .07 second dose versus control : p < 0.001
third and fourth & ;., s versus control .
of the greater available color Doppler flow mapping area in
the left anterior descending coronary artery . In fact, Doppler
color signal length and width increased from 5 .75 = 5 .32 and
1 .51 ± 1 .17 to 17 .04 ± 8 .76 and 4 .21 ± 1 .78 mm (p < 0 .0001) .
respectively, after intravenous SHU 508A injection (Fig . 5) .
The duration of the increased Doppler intensity after
contrast injection was 117 ± 29 s after 5-ml injection of
200 mg/ml, 135 ± 26 s after 10 ml of 200 mg/ml, 130 + 28 s
after 5 ml of 300
mg/ml
and 140 ± 23 s after 10 ml of
300 mg/ml (p ~- NS) . Inter- and intraobserver variability in
evaluating both color and pulsed wave Doppler recordings
,.vas low . Agreement was obtained in 85% of specific seg-
ment observations by the same observer and in 80% of
specific segment observations by two different observers .
Discussion
A major limitation of transesophageal Doppler echocar-
diographic evaluation of blood flow in the coronary arteries
is the low Doppler signal intensity caused by ultrasound
attenuation or low blood echogenicity . This makes color
Doppler flow mapping sometimes inadequately depicted, the
positioning of pulsed Doppler volume sampling difficult and
the quality of Doppler-obtained coronary blood flow velocity
tracings not sufficiently valid for quantitative measurements .
Therefore, to make transesophageal Doppler echocardio-
graphic evaluation of :,-oronary blood flow velocity more
useful and practical from the clinical and research point of
view (2), the feasibility of the method and the intensity (and
consequent quality of the tracings) of Doppler signals must
be improved . To achieve this goal, we used SHU 508A
(11-13), a new echo contrast agent consisting of a suspension
of galactose microparticles (mean diameter 2 gm), during
transesophageal echocardiographic study . Recent studies
(11,13) including a European multicenter trial (16,17), have
188
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demonstrated its safety and capability in considerably en-
hancing Doppler signal intensity and signal to noise ratio
after peripheral intravenous injection, not only in the right
heart chamber but also in the left atrium and left ventricle .
This enhancement of left heart Doppler signals is due to the
intravascular stability of SHU 508A, which allows the echo
enhancement of the blood to survive pulmonary transit after
MCC Vol. 23, No. I
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Figure 3 . Transesophageal color
Doppler flow mapping of blood flow
in the left anterior descending cor-
onary artery (LAD) before (upper
purls) and after (lower panels) in-
travenous injection of SHU 508A .
The right panels represent the dia-
grams. Baseline color Doppler flow
mapping (upper pme6) is incom-
plete (very short and narrow blue
signal that does not fill the vessel
section) . After intravenous injection
of SHU 503A (lower panels), the
color Doppler signal becomes much
longer and wider (complete flow
mapping). The flow is coded in blue
because it recedes from the trans-
ducer . Ao = aortic root ; LA = left
atrium ; LAD = left anterior descend-
ing coronary artery ; RVOT = right
ventricle outflow tract .
intravenous injection . Our results also clearly show that
peripheral injection of SHU 508A considerably enhances
Doppler signal intensity in the coronary arteries . After
injection, 67% of coronary segments were optimally opaci-
Red by color Doppler flow mapping compared with only 11%
before injection. Furthermore, both the length and width of
the color Doppler signal in the left anterior descending
Figure 4. Transesophageal color
Doppler flow mapping of blood flow
in the left circumflex coronary ar-
tery (LCA) before (upper panels)
and after (lower pamells) intravenous
injection of SHU 508A . The right
paned represent the diagrams .
Baseline Doppler color mapping
(upper panels) does not show any
signal related to flow . After intrave-
nous injection of SHU 508A (lower
panels), a red Doppler signal (be-
cause the flow is toward the probe)
becomes clearly identifiable in the
whole vessel B mode section (com-
plete flow mapping) . Moreover, en-
hancement of Doppler signal can
also be observed in the left atrium
(red area), which is clearly sepa-
rated from the circumflex by a B
mode linear strong reflection of left
atrium (LA)-circumflex artery in-
terface . Ao = aortic root ; RVOT
right ventricular outflow tract .
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Figure S . Pulsed wave Doppler recordl-
ang of coronary blood flow velocity in
the left anterior descending coronary
artery before (left panel) and after
(right intravenous injection o
SHU 508A . Before SFIU 509A, coro-
nary blood flow velocity is not detected
(only spikes and wall artifacts are re-
corded) . After SITU 505A, a typical
biphasic coronary blood flow velocity
pattern (greater diastolic, smaller sys-
tolic component) is recorded and
clearly outlined .
coronary artery increased . In our experience, this results in
a faster and much easier positioning and optimization of the
pulsed Doppler sample volume. As a result of better sample
volume positioning and enhanced signal to noise ratio, the
quality of the pulsed Doppler obtained coronary blood flow
velocity tracing also considerably improved . In our series,
coronary blood flow velocity could not be recorded at all in
10 patients (29%) before and in only 4 (11%) after echo
contrast injection. In addition, an optimal pulsed wave
Doppler recording of coronary blood flow velocity in the left
anterior descending artery was obtained in 23 patients (66%)
after SHU 508A injection and in only 8 patients (23%) before
injection . Lastly, the duration of the echo contrast effect was
long enough (>100 s in all patients) to allow adequate
recording of both color and pulsed wave Doppler signals .
Thus, our initial hypothesis that intravenous injection of the
transpulmonary echo contrast agent SHU 508A could im-
prove the Doppler signal to noise ratio was confirmed .
Conclusions. In this study, we demonstrated that the
feasibility of our recently described method of transesopha-
geal Doppler echocardiographic evaluation of coronary
blood flow reserve and coronary flow reserve (2) can be
considerably improved by injecting a small amount of a
lung-crossing echo contrast agent (SHU 508A) into a periph-
eral vein, After SHU 508A injection, the intensity of both
color and pulsed wave Doppler signals increases substan-
tially and the possibility of recording high quality coronary
blood flow reserve tracing considerably improves .
Echo contrast enhancement of Doppler signal intensity in
coronary arteries, along with recently developed omniplane
transesophageal probes (20) that are capable of wide orien-
tation in the space of ultrasound tomographic planes, should
result in more appropriate coronary artery imaging. These
improvements should make transesophageal Doppler
1L!CFTO -T Al-
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echocardiographic evaluation of coronary blood flow veloc-
ity characteristics and coronary flow reserve more feasible
and therefore more appropriate for clinical and research use .
We thank Rosalind Lee, MA for assistance in the preparation of the manu-
script .
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